Enrique Rojas of ESPN Deportes reports that Robinson Cano flew to Seattle to meet with the Mariners today and they’re willing to offer him a 10-year contract worth as much as $240 million.
Previous reports claim the Yankees aren’t willing to go as high as $200 million, so if Rojas’ information is correct the money isn’t even close.
Mariners general manager Jack Zduriencik predictably declined to comment about Cano specifically when asked yesterday, but was surprisingly open about the possibility of making a huge splash in free agency and sure sounded like someone who thought he had a real chance to land the second baseman.
Of course, $240 million tends to do that.
MLB.com’s Rhett Bollinger reports that Twins shortstop Jorge Polanco has been suspended 80 games after testing positive for the performance-enhancing drug Stanozolol.
In a statement, via Dan Hayes of The Athletic, Polanco denied knowingly using the substance. Polanco said, “To be clear, I did not intentionally consume this steroid. I now know, however, that my intention alone is not a good enough excuse and I will pay the price for my error in judgment. The substance that I requested from my athletic trainer in the Dominican Republic and consented to take was a combination of vitamin B12 and an iron supplement, something that is not unusual or illegal for professional athletes to take. Unfortunately, what I was given was not that supplement and I take full responsibility for what is in my body.”
Last year was Polanco’s first full season in the majors. He hit .256/.313/.410 with 13 home runs, 74 RBI, 60 runs scored, and 13 stolen bases in 544 plate appearances.
The Twins have Ehire Adrianza and Erick Aybar to handle shortstop while Polanco is out. The club could also give the starting job to prospect Nick Gordon, ranked No. 4 in the Twins’ system according to MLB Pipeline. Gordon had a solid 2017 campaign at Double-A Chattanooga, posting a .749 OPS with 29 doubles and 13 steals in 578 PA.